Calmodulin (CaM) regulation of the Ca~V~1--2 family of Ca^2+^ channels ranks among the most consequential of biological Ca^2+^ decoding systems^[@R1],[@R2]^. In this regulation, the Ca^2+^-free form of CaM (apoCaM) already preassociates with channels^[@R3]--[@R5]^, ready for ensuing Ca^2+^-driven modulation of channel opening. Upon elevation, intracellular Ca^2+^ binds to this indwelling CaM, driving conformational changes that enhance opening in some channels^[@R6]--[@R8]^ (positive-feedback 'facilitation'), and inhibit opening in others^[@R9],[@R10]^ (negative-feedback 'inactivation'). Intriguingly, Ca^2+^ binding to the individual C- and N-terminal lobes of CaM can semiautonomously induce distinct components of channel regulation^[@R7],[@R9],[@R11]^, where the C-lobe responds well to Ca^2+^ entering through the channel on which the corresponding CaM resides ('local Ca^2+^ selectivity'), and the N-lobe may in some channels require the far weaker Ca^2+^ signal from distant Ca^2+^ sources^[@R6],[@R7],[@R12]--[@R14]^ ('global Ca^2+^ selectivity'). Such Ca^2+^ feedback regulation influences many biological functions^[@R1],[@R15]--[@R17]^, and furnishes mechanistic lessons for Ca^2+^ decoding^[@R14]^. Indeed, CaM regulation of L-type (Ca~V~1.2) channels strongly influences cardiac electrical stability^[@R15],[@R18]^, and pharmacological manipulation of such regulation looms as a future antiarrhythmic strategy^[@R18],[@R19]^.

Crucial for understanding and manipulating this CaM regulatory system is identification of the conformations that underlie such Ca^2+^ modulation. [Figure 1a](#F1){ref-type="fig"} summarizes the currently accepted conceptual framework, with specific reference to L-type Ca~V~1.3 channels for concreteness. Configuration *E* ('empty' of CaM) represents channels lacking preassociated Ca^2+^-free CaM (apoCaM). Such channels can open normally, but do not exhibit Ca^2+^/CaM-dependent inactivation (CDI) over the typical \~300-msec duration of channel-activity measurements^[@R20]^. Over this period, Ca^2+^/CaM from the bulk solution cannot appreciably access a channel in configuration *E* to produce CDI^[@R20]--[@R23]^. ApoCaM preassociation with configuration *E* yields channels in configuration *A*, where opening can also proceed normally, but subsequent CDI can now ensue. *A* thereby denotes channels that are 'active' and capable of CDI. Switching between configurations *E* and *A* occurs slowly (\>10s of secs^[@R24]^), and almost exclusively involves apoCaM, because typical experiments only briefly activate Ca^2+^ channels every 20--30 secs. Thus, there is negligible exchange with configuration *E* during typical measurements of current. Regarding CDI, Ca^2+^ binding to both lobes of CaM yields configuration *I*~CN~ (both C and N lobes of CaM engaged towards CDI), corresponding to a fully inactivated channel with strongly reduced opening^[@R2],[@R25]^. As for intermediate configurations^[@R7],[@R9],[@R11],[@R14],[@R26]^, Ca^2+^ binding only to the C-lobe induces configuration *I*~C~, representing a C-lobe inactivated channel with reduced opening; Ca^2+^ binding only to the N-lobe yields an analogous N-lobe inactivated configuration (*I*~N~), also with reduced opening. Subsequent entry into configuration *I*~CN~ likely involves cooperative interactions denoted by a λ symbol. Overall, CDI reflects redistribution from configuration *A* into *I*~C~, *I*~N~, and *I*~CN~. Of note, we exclude cases where one Ca^2+^ binds a lobe of CaM, because binding within lobes is highly cooperative^[@R27]^. Moreover, only one CaM is included, based on multiple lines of evidence^[@R22],[@R23]^.

The structural basis of this conceptual foundation is less certain, but has been dominated by an IQ-centric hypothesis, where an IQ domain, present on the carboxy termini of all Ca~V~1--2 channels^[@R2]^ ([Fig. 1a](#F1){ref-type="fig"}, far right, blue circle), serves as the dominant CaM binding locus on the channel. By this hypothesis, not only does this element comprise much of the preassociation surface for apoCaM^[@R4],[@R5],[@R20]^ ([Fig. 1a](#F1){ref-type="fig"}, configuration *A*), it also constitutes the primary effector site^[@R2],[@R5],[@R7],[@R9],[@R10],[@R25],[@R28]^ for Ca^2+^/CaM rebinding to induce Ca^2+^ regulation (e.g., [Fig. 1a](#F1){ref-type="fig"}, *I*~CN~). The predominance of the IQ-centric paradigm^[@R2]^ has prompted resolution of several crystal structures of Ca^2+^/CaM complexed with IQ-domain peptides of various Ca~V~1--2 channels^[@R29]--[@R32]^.

Nonetheless, certain findings fit poorly with this viewpoint. Firstly, crystal structures of Ca^2+^/CaM complexed with wild-type and mutant IQ peptides of Ca~V~1.2 indicate that a signature isoleucine in the IQ element is deeply buried within the C-lobe of Ca^2+^/CaM, and that alanine substitution at this isoleucine negligibly perturbs structure^[@R30]^. Moreover, Ca^2+^/CaM affinities for analogous wild-type and mutant IQ peptides are nearly identical^[@R28]^. How then does alanine substitution at this well-encapsulated locus influence the rest of the channel to strongly disrupt functional regulation^[@R30]^? Secondly, in Ca~V~1.2/1.3 channels, we have demonstrated that the effector interface for the N-lobe of Ca^2+^/CaM resides within an NSCaTE element of the channel amino terminus^[@R13],[@R14],[@R33]^ ([Fig. 1a](#F1){ref-type="fig"}, far right), separate from the IQ element. Thirdly, analysis of the atomic structure of Ca^2+^/CaM bound to an IQ peptide of Ca~V~2.1 channels hints that the C-lobe effector site also resides somewhere outside the IQ module^[@R31]^. In all, the long disconnect between challenges like these and IQ-centric theory represents a critical impasse in the field.

A major concern with prior IQ-domain analyses is that function was mostly characterized with only endogenous CaM present^[@R5],[@R10],[@R25],[@R28],[@R31]^. This regime is problematic because IQ-domain mutations could alter CaM regulation via perturbations at multiple steps within [Fig. 1a](#F1){ref-type="fig"}, whereas interpretations mainly ascribe effects to altered Ca^2+^/CaM binding with an IQ effector site. Serious interpretive challenges thus include: (1) While the high apoCaM affinity of most wild-type channels^[@R4],[@R20]^ renders configuration *E* unlikely ([Fig. 1a](#F1){ref-type="fig"}), this may not hold true for mutant channels, just as observed for certain Ca~V~1.3 splice variants^[@R20]^. Mutations weakening apoCaM preassociation could thereby reduce CDI by favoring configuration *E* ([Fig. 1a](#F1){ref-type="fig"}, incapable of CDI), without affecting Ca^2+^/CaM binding. (2) Mutations that do weaken interaction with one lobe of Ca^2+^/CaM may have their functional effects masked by cooperative steps (λ in [Fig. 1a](#F1){ref-type="fig"}).

This study systematically investigates the IQ-centric hypothesis, minimizing the above challenges by focusing on Ca~V~1.3 channels, a representative L-type channel whose CDI is particularly robust and separable into distinct C- and N-lobe components^[@R11],[@R13],[@R14]^. These attributes simplify analysis as follows. For orientation, [Fig. 1b](#F1){ref-type="fig"} illustrates the CDI of Ca~V~1.3 channels expressed in HEK293 cells, with only endogenous CaM present. Strong CDI is evident from the rapid decay of whole-cell Ca^2+^ current (black trace), compared with the nearly absent decline of Ba^2+^ current (gray trace). Because Ba^2+^ binds negligibly to CaM^[@R34]^, the fractional decline of Ca^2+^ versus Ba^2+^ current after 300-ms depolarization quantifies the steady-state extent of CDI ([Fig. 1b](#F1){ref-type="fig"}, right, *CDI* parameter). The CDI here reflects the operation of the entire [Fig. 1a](#F1){ref-type="fig"} system, as schematized at the bottom of [Fig. 1b](#F1){ref-type="fig"}. We can formally isolate the diamond-shaped subsystem lacking configuration *E* ([Fig. 1c](#F1){ref-type="fig"}, bottom), by using mass action and strong overexpression of wild-type CaM (CaM~WT~). The resulting CDI ([Fig. 1c](#F1){ref-type="fig"}) is indistinguishable from that with only endogenous CaM present ([Fig. 1b](#F1){ref-type="fig"}), owing to the high apoCaM affinity of wild-type Ca~V~1.3 channels. Full deconstruction of CDI arises upon strong coexpression of channels with a mutant CaM that only allows Ca^2+^ binding to its C-terminal lobe^[@R9]^ ([Fig. 1d](#F1){ref-type="fig"}, CaM~12~). With reference to [Fig. 1a](#F1){ref-type="fig"}, this maneuver depopulates configuration *E* by mass action, and forbids access into configurations *I*~N~ and *I*~CN~. Thus, the isolated C-lobe component of CDI^[@R11],[@R14]^ is resolved ([Fig. 1d](#F1){ref-type="fig"}), with its signature rapid timecourse of current decay. Importantly, this regime avoids interplay with cooperative λ steps in [Fig. 1a](#F1){ref-type="fig"}. Likewise, strongly coexpressing mutant CaM exhibiting Ca^2+^ binding to its N-lobe alone^[@R9]^ (CaM~34~) isolates the slower N-lobe form of CDI^[@R11],[@R14]^ ([Fig. 1e](#F1){ref-type="fig"}), with attendant simplifications. Thus armed, we here exploit selective monitoring of Ca~V~1.3 subsystems ([Fig. 1b--e](#F1){ref-type="fig"}), combined with alanine scanning mutagenesis of the entire carboxyl tail of Ca~V~1.3 channels. In so doing, we argue against the IQ-centric paradigm, and propose a new framework for the CaM regulation of Ca^2+^ channels.

RESULTS {#S1}
=======

iTL analysis of CaM/channel regulation {#S2}
--------------------------------------

Identifying channel effector interfaces for Ca^2+^/CaM is challenging. The main subunit of Ca~V~ channels alone spans about two-thousand amino acids or more; and peptide assays indicate that Ca^2+^/CaM can bind to multiple segments of uncertain function^[@R25],[@R35]--[@R39]^. Even if mutating these segments alters CaM regulation, the observed functional effects could reflect perturbations of apoCaM preassociation, Ca^2+^/CaM binding, or transduction. To address these challenges, we initially consider an expanded conceptual layout believed valid for either isolated N- or C-lobe CDI^[@R14]^ ([Fig. 2a](#F2){ref-type="fig"}), then deduce from this arrangement a simple quantitative analysis to identify *bona fide* effector interfaces. An apoCaM lobe begins prebound to a channel preassociation surface (state 1). Ca^2+^ binding to CaM in this prebound state is considered rare^[@R14],[@R40]^. However, after apoCaM releases (state 2), it may bind Ca^2+^ to produce Ca^2+^/CaM (state 3), or return to state 1. The transiently dissociated lobe of CaM (state 2 or 3) remains within a channel alcove over the usual timescale of CaM regulation (≤ seconds). Finally, Ca^2+^/CaM binds a channel effector site (state 4, square pocket), ultimately inducing regulation via transduction to state 5. Emergent behaviors of this scheme rationalize local and global Ca^2+^ selectivities, as argued previously^[@R14]^.

Despite the multiple transitions present even for this reduced CDI subsystem ([Fig. 2a](#F2){ref-type="fig"}, left schematics), a straightforward relationship emerges that will aid detection of Ca^2+^/CaM interfaces on the channel, as follows. Suppose we can introduce point alanine mutations into the channel that selectively perturb the Ca^2+^/CaM binding equilibrium association constant γ~1~ ([Fig. 2a](#F2){ref-type="fig"}). Also suppose we can measure Ca^2+^/CaM binding to a corresponding channel peptide, and the affiliated association constant *K*~a,EFF~ is proportional to γ~1~ in the channel. It then turns out that our metric of inactivation (*CDI* in [Fig. 1b](#F1){ref-type="fig"}) will always be given by the Langmuir function $$CDI = CDI_{\text{max}} \cdot K_{a,EFF}/(K_{a,EFF} + \land )$$ where *CDI*~max~ is the value of *CDI* if *K*~a,EFF~ becomes exceedingly large, and Λ is a constant comprised of other association constants in the layout ([Supplementary Note 1](#SD1){ref-type="supplementary-material"}). [Figure 2b](#F2){ref-type="fig"} plots this function, where the green symbol marks a hypothetical wild-type-channel position, and mutations should create data symbols that decorate the remainder of the curve. Importantly, the requirement that peptide *K*~a,EFF~ need only be proportional to (not equal to) holochannel γ~1~ increases the chances that tagged peptides may suffice to correlate with holochannel function. Additionally, [Eq. 1](#FD1){ref-type="disp-formula"} will hold true only if these two suppositions are satisfied ([Supplementary Note 2](#SD1){ref-type="supplementary-material"}). For example, if mutations alter two transitions within the holochannel, a function with different shape will result. Alternatively, if mutations change the peptide interaction with Ca^2+^/CaM (*K*~a,EFF~), but not any of the actual association constants within the channel, the outcome in [Fig. 2c](#F2){ref-type="fig"} will emerge. In this case, though the channel peptide can bind Ca^2+^/CaM in isolation, this reaction has no bearing on transitions within the intact holochannel ([Fig. 2a](#F2){ref-type="fig"}). By contrast, [Fig. 2d](#F2){ref-type="fig"} diagrams a scenario where mutations actually do affect transition(s) governing CDI within the holochannel, yet altogether fail to perturb Ca^2+^/CaM binding to a peptide segment of the channel. It is also possible that mutations could affect transition(s) governing CDI within the holochannel, but in ways that are uncorrelated with mutational perturbations of Ca^2+^/CaM binding to a corresponding peptide segment ([Fig. 2e](#F2){ref-type="fig"}). The red symbol denotes a specific subset of this scenario, where a mutation affects transition(s) within the holochannel so as to enhance CDI, whereas the same mutation produces uncorrelated diminution of Ca^2+^/CaM binding to a peptide segment of the channel. Yet other deviations from [Eq. 1](#FD1){ref-type="disp-formula"} are possible, including those arising from the existence of effector sites beyond our alanine scan ([Supplementary Note 3](#SD1){ref-type="supplementary-material"}). Importantly, these outcomes will pertain regardless the size and complexity of the scheme in [Fig. 2a](#F2){ref-type="fig"} ([Supplementary Note 4](#SD1){ref-type="supplementary-material"}). Because of this generality, we term the analysis individually Transformed Langmuir (iTL) analysis.

Given this insight, we undertook alanine-scanning mutagenesis of Ca~V~1.3 channel domains, and screened electrophysiologically for altered CaM regulatory hotspots. In parallel, we introduced hotspot mutations into peptides overlapping scanned regions, and estimated *K*~a,EFF~ of potential CaM binding. For this purpose, we utilized live-cell FRET two-hybrid assays^[@R3],[@R4],[@R41]^, which have the resolution and throughput for the task. If such binding truly reflects holochannel function, then *CDI* should vary with *K*~a,EFF~ as a Langmuir function ([Eq. 1](#FD1){ref-type="disp-formula"}, [Fig. 2b](#F2){ref-type="fig"}). By contrast, if *K*~a,EFF~ changes in a manner unrelated to holochannel CDI, data would diverge from [Eq. 1](#FD1){ref-type="disp-formula"} ([Fig. 2c--e](#F2){ref-type="fig"}, or otherwise). CaM effector interfaces could thus be systematically resolved.

iTL analysis of IQ domain as Ca^2+^/CaM effector site {#S3}
-----------------------------------------------------

We first addressed whether the Ca~V~1.3 IQ domain serves as a Ca^2+^/CaM effector site for CDI, as IQ-centric theory postulates. Single alanines were substituted at each position of the entire IQ domain of Ca~V~1.3 channels, whose sequence appears atop [Fig. 3a](#F3){ref-type="fig"} with the signature isoleucine bolded at position '0.' Naturally occurring alanines were changed to threonine. CDI of these mutants was then characterized for the isolated N- and C-lobe CDI subsystems described above ([Fig. 3a, b](#F3){ref-type="fig"}, left schematics), thus minimizing potential complications from diminished preassociation with apoCaM ([Fig. 1a](#F1){ref-type="fig"}, configuration *E*), or masking of CDI effects by cooperative λ steps ([Fig. 1a](#F1){ref-type="fig"}). Whereas little deficit in N-lobe CDI was observed ([Fig. 3a](#F3){ref-type="fig"}), C-lobe CDI was strongly attenuated by alanine substitutions at I\[0\]A ([Fig. 3b](#F3){ref-type="fig"}, red bar, exemplar traces) and nearby positions (rose). To test for correspondence between reductions in C-lobe CDI and altered Ca^2+^/CaM binding, we performed FRET 2-hybrid assays of Ca^2+^/CaM binding to alanine-substituted IQ peptides, with substitutions encompassing sites associated with the strongest CDI effects ([Fig. 3b](#F3){ref-type="fig"}, red and rose bars). Hatched bars denote additional sites chosen at random. The left aspect of [Fig. 3c](#F3){ref-type="fig"} cartoons the FRET interaction partners, and the right portion displays the resulting binding curve for the wild-type IQ peptide ([Fig. 3c](#F3){ref-type="fig"}, right, black). *FR*-1 is proportional to FRET efficiency, as indicated by the efficiency *E*~A~ scale bar on the right. *D*~free~ is the free concentration of donor-tagged molecules (CFP--CaM), where 200 nM \~6100 *D*~free~ units^[@R4],[@R42]^. At odds with a Ca^2+^/CaM effector role of the IQ domain, the binding curve for the I\[0\]A substitution ([Fig. 3c](#F3){ref-type="fig"}, right, red) resembled that for the wild-type peptide (black), whereas C-lobe CDI was strongly decreased ([Fig. 3b](#F3){ref-type="fig"}). [Figure 3c](#F3){ref-type="fig"} (middle) displays a bar-graph summary of the resulting association constants (*K*~a,EFF~); the wild-type value is shown as a dashed green line, and that for I\[0\]A as a red bar ([Supplementary Note 5](#SD1){ref-type="supplementary-material"}). If the IQ domain were the effector site for the C-lobe of Ca^2+^/CaM, C-lobe CDI over various substitutions should correlate with association constants according to [Eq. 1](#FD1){ref-type="disp-formula"} ([Supplementary Notes 1 and 6](#SD1){ref-type="supplementary-material"}). However, plots of our data markedly deviate from such a relation ([Fig. 3e](#F3){ref-type="fig"}), much as in [Fig. 2e](#F2){ref-type="fig"}. The green symbol denotes the wild-type IQ case. Likewise, plots of N-lobe CDI versus *K*~a,EFF~ deviated from a Langmuir ([Fig. 3d](#F3){ref-type="fig"}), much as in [Fig. 2c](#F2){ref-type="fig"}. These outcomes fail to support the IQ domain as an effector site for either lobe of Ca^2+^/CaM. The actual role of the IQ domain in CDI will be explored later in [Fig. 6](#F6){ref-type="fig"}.

To undertake a still more stringent test, we investigated a Y\[3\]D construct, based on a prior analogous mutation in Ca~V~2.1 that intensely diminished Ca^2+^/CaM affinity^[@R31]^. Indeed, the Y\[3\]D substitution in Ca~V~1.3 resulted in a large 13.5-fold decrement in *K*~a,EFF~ ([Fig. 3c](#F3){ref-type="fig"}, blue symbol). However, there was no change in C- or N-lobe CDI ([Fig. 3a, b](#F3){ref-type="fig"}, blue symbols; [Supplementary Note 7](#SD1){ref-type="supplementary-material"}). These data deviated yet more strongly from a Langmuir (blue symbols, [Fig. 3d, e](#F3){ref-type="fig"}), arguing further against the IQ domain as a Ca^2+^/CaM effector site.

NSCaTE element upheld as effector site for N-lobe of Ca^2+^/CaM {#S4}
---------------------------------------------------------------

Absent a positive outcome for iTL analysis of the IQ domain (i.e., [Fig. 2b](#F2){ref-type="fig"}), we turned to the amino-terminal NSCaTE module ([Fig. 4a](#F4){ref-type="fig"}, oval), previously proposed as an effector site for N-lobe CDI^[@R13],[@R14]^. For reference, [Fig. 4b](#F4){ref-type="fig"} displays the wild-type Ca~V~1.3 profile for N-lobe CDI. Single alanines were substituted across the NSCaTE module ([Fig. 4d](#F4){ref-type="fig"}, top), at residues that were not originally alanine. The bar-graph summary below ([Fig. 4d](#F4){ref-type="fig"}) indicates strongly diminished N-lobe CDI upon alanine substitution at three residues, previously identified as critical^[@R13],[@R14]^ (W\[44\]A, I\[48\]A, and R\[52\]A). For comparison, the wild-type level of CDI is represented by the green dashed line and affiliated error bars. W\[44\]A featured the strongest CDI decrement, as shown by the Ca^2+^ current ([Fig. 4b](#F4){ref-type="fig"}, red trace) and population data ([Fig. 4d](#F4){ref-type="fig"}, red bar). To pursue iTL analysis, we characterized corresponding binding curves between NSCaTE and Ca^2+^/CaM~34~ FRET pairs ([Fig. 4c](#F4){ref-type="fig"}, left; [Supplementary Note 8](#SD1){ref-type="supplementary-material"}). The wild-type pairing exhibited a well-resolved binding curve with *K*~a,EFF~ = 4×10^−4^ *D*~free~^−1^ units ([Fig. 4c](#F4){ref-type="fig"}, right, black), whereas the W\[44\]A variant yielded a far lower affinity with *K*~a,EFF~ \~0 (red). A summary of binding affinities is shown for this and additional mutations within NSCaTE in [Fig. 4e](#F4){ref-type="fig"} ([Supplementary Note 9](#SD1){ref-type="supplementary-material"}), where the dashed-green line signifies the wild-type profile. The crucial test arises by plotting N-lobe CDI as a function of *K*~a,EFF~, which resolves the Langmuir relation in [Fig. 4f](#F4){ref-type="fig"}. For reference, wild type is shown in green, and W\[44\]A in red. The particular formulation of [Eq. 1](#FD1){ref-type="disp-formula"} for this arrangement is given in [Supplementary Note 1](#SD1){ref-type="supplementary-material"}. Hence, iTL analysis does uphold NSCaTE as a predominate effector site for N-lobe CDI, as argued before by other means^[@R13],[@R14]^. By contrast, analysis of C-lobe CDI ([Fig. 4g-k](#F4){ref-type="fig"}; [Supplementary Note 10](#SD1){ref-type="supplementary-material"}) reveals deviation from [Eq. 1](#FD1){ref-type="disp-formula"} ([Fig. 4l](#F4){ref-type="fig"}), much as in [Fig. 2c](#F2){ref-type="fig"}. Thus, NSCaTE mutations have little bearing on C-lobe CDI of the holochannel, though such mutations affect Ca^2+^/CaM~12~ binding to an isolated NSCaTE peptide.

Identification of the C-lobe Ca^2+^/CaM effector interface {#S5}
----------------------------------------------------------

Satisfied by proof-of-principle tests of the iTL approach, we turned to identification of the as-yet-unknown effector site for the C-lobe form of CDI. Our screen focused upon the entire carboxy tail of Ca~V~1.3 channels upstream of the IQ domain ([Fig. 5a](#F5){ref-type="fig"}, PCI domain), because switching these carboxy-terminal segments in chimeric channels sharply influences this type of CDI^[@R31],[@R43]^. For completeness, we initially characterized isolated N-lobe CDI for mutations throughout the PCI, and found no appreciable decrement from wild-type levels ([Fig. 5b, e](#F5){ref-type="fig"}; [Supplementary Note 12](#SD1){ref-type="supplementary-material"}), as expected. Gaps indicate nonexpressing configurations. By contrast, for isolated C-lobe CDI, the sharp diminution of CDI upon LGF→AAA substitution ([Fig. 5c, f](#F5){ref-type="fig"}, red) exemplifies just one of many newly discovered 'hotspot' loci residing in the PCI midsection ([Fig. 5f](#F5){ref-type="fig"}, rose and red; [Supplementary Note 12](#SD1){ref-type="supplementary-material"}). As a prelude to iTL analysis, we determined the binding of Ca^2+^/CaM to the PCI element ([Fig. 5g](#F5){ref-type="fig"}, left cartoon), and indeed the LGF substitution weakens interaction affinity ([Fig. 5d](#F5){ref-type="fig"}). Likewise, binding of the isolated C-lobe of Ca^2+^/CaM to PCI was similarly attenuated by the LGF mutation ([Supplementary Note 11](#SD1){ref-type="supplementary-material"}), arguing explicitly for disruption of a C-lobe interface. Additionally, for loci demonstrating the strongest reduction in C-lobe CDI ([Fig. 5f](#F5){ref-type="fig"}, rose and red), corresponding Ca^2+^/CaM affinities were determined to also attenuate *K*~a,EFF~ ([Fig. 5g](#F5){ref-type="fig"}; [Supplementary Notes 11--12](#SD1){ref-type="supplementary-material"}). Importantly, graphing C-lobe CDI versus binding affinity strikingly resolves a Langmuir relation ([Fig. 5i](#F5){ref-type="fig"}), furnishing compelling evidence that the PCI midsection comprises an effector interface for the C-lobe of Ca^2+^/CaM. The green symbol corresponds to wild type, and the red datum to the LGF mutant. [Supplementary Note 1](#SD1){ref-type="supplementary-material"} specifically formulates [Eq. 1](#FD1){ref-type="disp-formula"} for this case. As expected, plots of N-lobe CDI versus binding affinity deviate from a Langmuir ([Fig. 5h](#F5){ref-type="fig"}), much as in [Fig. 2c, e](#F2){ref-type="fig"}. Overall, the impressive mirror-like inversion of results for NSCaTE ([Fig. 4f, l](#F4){ref-type="fig"}) and PCI ([Fig. 5h, i](#F5){ref-type="fig"}) underscores the considerable ability of iTL analysis to distinguish between effector sites of respective N- and C-lobe CDI.

C-lobe CDI also requires IQ domain interaction with the PCI element {#S6}
-------------------------------------------------------------------

Though the IQ domain alone does not appear to be an effector site for Ca^2+^/CaM ([Fig. 3](#F3){ref-type="fig"}), alanine substitutions in this element nonetheless attenuated C-lobe CDI^[@R7],[@R10],[@R11],[@R28],[@R31]^, a result reproduced for reference in [Fig. 6a, b](#F6){ref-type="fig"}. Might the departure of Ca^2+^/CaM to NSCaTE ([Fig. 4](#F4){ref-type="fig"}) and PCI elements ([Fig. 5](#F5){ref-type="fig"}) then allow the IQ domain to rebind elsewhere, in a manner also required for C-lobe CDI? Thus viewed, IQ-domain mutations could diminish C-lobe CDI by weakening this rebinding, but in a way that correlates poorly with IQ-peptide binding to Ca^2+^/CaM in isolation. Because C-lobe CDI can be conferred to Ca~V~2 channels by substituting PCI and IQ elements from Ca~V~1^[@R31],[@R43]^, might the requisite rebinding involve association between these very elements?

Initially disappointing was the existence of only low affinity binding between IQ and PCI modules ([Fig. 6c](#F6){ref-type="fig"}, left cartoon; [Fig. 6d](#F6){ref-type="fig"}, gray) under conditions of resting intracellular calcium^[@R3]^. By contrast, under elevated Ca^2+^, robust interaction between the same IQ/PCI FRET pair was observed, with *K*~a-PCI--IQ~ = 4.35 × 10^−5^ *D*~free~ units^−1^ ([Fig. 6d](#F6){ref-type="fig"}, black). In fact, this Ca^2+^-dependent interaction accords well with a role in triggering CDI, and likely arises from a requirement for Ca^2+^/CaM to bind the PCI domain before appreciable IQ association occurs ([Supplementary Note 13](#SD1){ref-type="supplementary-material"}). Beyond mere binding, however, functionally relevant interaction would be decreased by the same IQ-domain mutations that reduced C-lobe CDI. In this regard, IQ peptides bearing I\[0\]A or Q\[1\]A substitutions actually demonstrated strong and graded reductions in affinity ([Fig. 5e](#F5){ref-type="fig"}, respective red and blue symbols), coarsely matching observed deficits in C-lobe CDI ([Fig. 5b](#F5){ref-type="fig"}). [Figure 5c](#F5){ref-type="fig"} summarizes the results of these and other FRET binding assays ([Supplementary Note 14](#SD1){ref-type="supplementary-material"}), performed for loci with the strongest effects on C-lobe CDI ([Fig. 6b](#F6){ref-type="fig"}, colored bars under dashed-gray threshold). With these data, quantitative iTL analysis could be undertaken, where the presumed CDI transition in question would be the γ~2~ transduction step in [Fig. 2a](#F2){ref-type="fig"}, and the relevant form of [Eq. 1](#FD1){ref-type="disp-formula"} is specified in [Supplementary Note 15](#SD1){ref-type="supplementary-material"}. Remarkably, plotting C-lobe CDI ([Fig. 6b](#F6){ref-type="fig"}) versus IQ/PCI binding affinity ([Fig. 6c](#F6){ref-type="fig"}) indeed resolves a Langmuir ([Fig. 6f](#F6){ref-type="fig"}). Thus, C-lobe CDI likely requires a tripartite complex of IQ, PCI, and C-lobe Ca^2+^/CaM ([Fig. 6a](#F6){ref-type="fig"}).

ApoCaM preassociation within the PCI domain {#S7}
-------------------------------------------

Having explored Ca^2+^/CaM, we turned to apoCaM interactions. Elsewhere^[@R42]^ we have shown that apoCaM preassociates with a surface that at least includes^[@R2],[@R4],[@R5],[@R20]^ the IQ element. Furthermore, homology modeling^[@R42]^ of a related apoCaM/IQ structure for Na~V~ channels^[@R44],[@R45]^ suggests that the Ca~V~1.3 IQ module interacts with the C-lobe of apoCaM. Might the N-lobe of apoCaM then bind the PCI domain ([Fig. 7a](#F7){ref-type="fig"})? If so, then our earlier PCI mutations could have weakened N-lobe apoCaM interaction, and potentially diminished CDI by favoring configuration *E* channels ([Fig. 1a](#F1){ref-type="fig"}, incapable of inactivation). This effect would not have been apparent thus far, because we invariably overexpressed CaM. However, with only endogenous wild-type CaM present in [Fig. 7e](#F7){ref-type="fig"}, CDI reflects the operation of a system that includes configuration *E* (left schematic), and the observed *CDI*~CaMendo~ is indeed strongly attenuated by mutations at many loci (rose and red bars).

We tested for decreased preassociation as the basis of this effect, by checking whether CDI resurged upon strongly overexpressing wild-type CaM (CaM~WT~). This maneuver should act via mass action to eliminate CaM-less channels^[@R20]^, restrict channels to the subsystem on the left of [Fig. 7f](#F7){ref-type="fig"}, and restore CDI. For all loci demonstrating appreciable reduction of *CDI*~CaMendo~ ([Fig. 7e](#F7){ref-type="fig"}, rose and red), CDI was measured under strongly overexpressed CaM~WT~ (*CDI*~CaMhi~), as summarized in [Fig. 7f](#F7){ref-type="fig"}. As baseline, we confirmed that elevating CaM~WT~ hardly affected CDI of wild-type channels (compare wild-type, dashed-green lines in [Fig. 7e, f](#F7){ref-type="fig"}). The high apoCaM affinity of wild-type channels renders configuration *E* channels rare, even with only endogenous apoCaM present^[@R20]^. By contrast, the TVM mutant exhibits an impressive return of CDI upon elevating CaM~WT~ ([Fig. 7b, c](#F7){ref-type="fig"}), as do many other mutants ([Fig. 7f](#F7){ref-type="fig"}; [Supplementary Note 16](#SD1){ref-type="supplementary-material"}). Critically, scrutiny of the underlying configurations ([Figs. 7e and 7f](#F7){ref-type="fig"}, left) reveals that *CDI*~CaMendo~ = *CDI*~CaMhi~ · *F*~b~, where *F*~b~ is the fraction of channels prebound to apoCaM with only endogenous CaM present. This relation holds true, even with a residual *CDI*~CaMhi~ shortfall compared to wild type (e.g., [Fig. 7f](#F7){ref-type="fig"}, LGF). This is so because a *CDI*~CaMhi~ deficit mirrors changes in the diamond subsystem of [Fig. 7f](#F7){ref-type="fig"} (left), which are identically present in *CDI*~CaMendo~ measurements ([Fig. 7e](#F7){ref-type="fig"}).

Thus aware, we tested whether apoCaM binding to the entire CI domain (spanning IQ and PCI modules) mirrors resurgent CDI ([Fig. 7g](#F7){ref-type="fig"}, left cartoon; [Supplementary Note 17](#SD1){ref-type="supplementary-material"}). The wild-type pairing showed robust interaction with *K*~a,EFF~ = 2.5 × 10^−4^ *D*~free~ units^−1^ ([Fig. 7d](#F7){ref-type="fig"}, black; [Fig. 7g](#F7){ref-type="fig"}, green dashed line). By contrast, the TVM pairing, corresponding to strong resurgent CDI ([Fig. 7b, c](#F7){ref-type="fig"}), exhibited far weaker affinity ([Fig. 7d, g](#F7){ref-type="fig"}, red; *K*~a,EFF~ = 0.13 × 10^−4^ *D*~free~ units^−1^). [Figure 7g](#F7){ref-type="fig"} tallies the graded decrease of *K*~a,EFF~ for these and other pairings ([Supplementary Note 16](#SD1){ref-type="supplementary-material"}).

Most rigorously, if PCI contacts indeed mediate apoCaM preassociation, then plotting *CDI*~CaMendo~ / *CDI*~CaMhi~ (= *F*~b~) versus the *K*~a,EFF~ for apoCaM/CI interaction ([Fig. 7g](#F7){ref-type="fig"}) should decorate a Langmuir relation ([Supplementary Note 18](#SD1){ref-type="supplementary-material"}). Indeed, just such a relation ([Fig. 7h](#F7){ref-type="fig"}) is resolved ([Fig. 7e--g](#F7){ref-type="fig"}), arguing that the N-lobe of apoCaM interfaces with corresponding PCI loci. Notably, this relation is identical to that reported elsewhere for IQ mutations on the same CI module^[@R42]^. [Figure 7i](#F7){ref-type="fig"} explicitly overlays PCI and IQ data (in blue), and this striking resolution of a single Langmuir accords with one and the same apoCaM binding PCI and IQ domains.

DISCUSSION {#S8}
==========

These experiments fundamentally transform the prevailing molecular view of CaM regulation of Ca^2+^ channels. The field has long been dominated by an IQ-centric scheme^[@R2],[@R5],[@R7],[@R9],[@R10],[@R25],[@R28]^, wherein indwelling apoCaM begins preassociated with a carboxy-terminal IQ domain, and remains bound to this element upon CaM interaction with Ca^2+^. Here, our new proposal establishes substantial exchange of CaM to alternate effector loci ([Fig. 8a](#F8){ref-type="fig"}). ApoCaM preassociates with an interface that includes, but is not limited to the IQ domain (configuration *A*): the C-lobe binds the IQ (cyan circle), and the N-lobe binds the central midsection of the PCI (green box). Ca^2+^ binding to the N-lobe yields configuration *I*~N~, wherein this lobe binds the NSCaTE module on the channel amino terminus (pink oval) to trigger N-lobe CDI. Ensuing Ca^2+^ binding to the C-lobe induces configuration *I*~CN~, with C-lobe binding the proximal PCI midsection (green square), and IQ engagement^[@R25]^. If Ca^2+^ only binds the C-lobe, the system adopts configuration *I*~C~, corresponding to C-lobe CDI. Ultimately, Ca^2+^/CaM exchange to effector loci diminishes opening, perhaps via allosteric coupling of carboxy-tail conformation to a contiguous IVS6 segment implicated in activation^[@R46],[@R47]^ and inactivation^[@R48]^. Only a single CaM is present^[@R22],[@R23]^ ([Supplementary Note 17](#SD1){ref-type="supplementary-material"}).

The structures of many of these configurations are presently unknown, but *ab initio* and homology modeling here confirms the plausibility of these configurations. Concerning the apoCaM/channel complex, [Figure 8b](#F8){ref-type="fig"} displays a homology model of the C-lobe complexed with the IQ domain^[@R42]^ (blue), based on an analogous atomic structure from Na~V~ channels^[@R44],[@R45]^. Key IQ-domain hotspots for apoCaM preassociation (red) are rationalized by this model^[@R42]^. To portray the N-lobe as shown in [Fig. 8b](#F8){ref-type="fig"}, we utilized *ab initio* structural prediction of the CI domain with the *Rosetta* package^[@R49]^ ([Supplementary Note 19](#SD1){ref-type="supplementary-material"}), yielding a PCI domain (green) with two vestigial EF hands, and a protruding helix ('preIQ' subelement). The EF-hand module (EF) resembles the structure of a homologous segment of Na~V~ channels^[@R50],[@R51]^, and a helical segment has been resolved in atomic structures of analogous Ca~V~1.2 segments^[@R36],[@R37]^. Reassuringly, N-lobe apoCaM hotspots adorn the surface of this PCI model (red coloration), within the more C-terminal of two EF hands. Accordingly, we appose the atomic structure of the N-lobe (1CFD) to this segment of the PCI model, initially using a shape-complementarity docking algorithm^[@R52]^ (*PatchDock*), followed by refinement with docking protocols of *Rosetta* ([Supplementary Note 20](#SD1){ref-type="supplementary-material"}). Of note, the configuration of the N-lobe explains the outright enhancement of N-lobe CDI by PCI mutations in the region of putative N-lobe contact (compare [Figs. 5e](#F5){ref-type="fig"} and [7e](#F7){ref-type="fig"}, GKL through TLF). Weakening channel binding to the N-lobe ([Fig. 2a](#F2){ref-type="fig"}, state 1) would, through connection to other states, increase state 5 occupancy, thereby boosting N-lobe CDI ([Supplementary Note 21](#SD1){ref-type="supplementary-material"}). By contrast, no N-lobe CDI enhancement was observed for IQ substitutions at the central isoleucine (I\[0\]) and downstream^[@R42]^, consistent with IQ binding the C-lobe of apoCaM.

[Figure 8c](#F8){ref-type="fig"} displays a model of Ca^2+^/CaM complexed with the channel. The N-lobe bound to NSCaTE is an NMR structure^[@R33]^, and functional N-lobe CDI hotspots correspond well with intimate contact points (red). C-lobe CDI hotspots also adorn the surface of the upstream EF-hand region of an alternative *ab initio* model of the PCI ([Fig. 8c](#F8){ref-type="fig"}, red; [Supplementary Note 19](#SD1){ref-type="supplementary-material"}). The IQ domain and atomic structure of the C-lobe of Ca^2+^/CaM (3BXL) were then computationally docked ([Supplementary Note 22](#SD1){ref-type="supplementary-material"}), yielding a rather canonical CaM/peptide complex where the channel contributes a surrogate lobe of CaM. Overall, this framework promises to set the table for future structural-biology and structure-function work.

More broadly, this regulatory scheme may explain paradoxes and open horizons. First, it has been asked how Ca^2+^/CaM could ever leave the IQ domain, when the binding affinity between these elements is so high^[@R4],[@R5],[@R29],[@R39],[@R53]^ (e.g., *K*~a/CaM--IQ~ = 5.88 × 10^−4^ *D*~free~^−1^ units in [Fig. 3c](#F3){ref-type="fig"}). The answer may arise from the competing binding affinity for the tripartite complex ([Fig. 8a](#F8){ref-type="fig"}, *I*~CN~), which multivalent ligand binding theory^[@R54]^ would approximate as *K*~a/CaM--PCI--IQ~ \~ *K*~a/CaM--PCI~ × *K*~a/PCI-IQ~ × (local concentration of IQ) = (4.35 × 10^−5^ *D*~free~ units^−1^) × (3.45 × 10^−5^ *D*~free~ units^−1^) × (1.36 × 10^8^ *D*~free~ units) \~ 0.2 *D*~free~ units^−1^, a value far larger than *K*~a/CaM--IQ~ ([Supplementary Note 23](#SD1){ref-type="supplementary-material"}). Second, our scheme offers new interfaces targetable by native modulators and drug discovery. As L-type channel CDI influences cardiac arrhythmogenic potential^[@R15],[@R18]^ and Ca^2+^ load in substantia nigral neurons prone to degeneration in Parkinson's^[@R55]^, one could envisage a screen for selective modulators of N- or C-lobe CDI^[@R19]^. Third, our results offer a fine-grained roadmap for Ca~V~1--2 splice/editing variants and channelopathies^[@R56]^. Indeed, we suspect that the design principles revealed here may generalize widely to other molecules modulated by CaM^[@R45],[@R50],[@R51],[@R57]^.

METHODS {#S9}
=======

Molecular biology {#S10}
-----------------

To simplify mutagenesis, the wildtype construct in this study was an engineered Ca~V~1.3 construct α~1DΔ1626~, nearly identical to and derived from the native rat brain variant (α~1D~, AF3070009). Briefly, the α~1DΔ1626~ construct, as contained with mammalian expression plasmid pCDNA6 (Invitrogen), features introduction of a silent and unique *Kpn* I site at a position corresponding to \~50 amino acid residues upstream of the carboxy terminal IQ domain (G~1538~T~1539~). As well, a unique *Bgl* II restriction site is present at a locus corresponding to \~450 amino acid residues upstream of the IQ domain. Finally, a unique *Xba* I and stop codon have been engineered to occur immediately after the IQ domain. These attributes accelerated construction of cDNAs encoding triple alanine mutations of α~1DΔ1626~. Point mutations of channel segments were made via QuikChange® mutagenesis (Agilent), prior to PCR amplification and insertion into the full-length α~1DΔ1626~ channel construct via restriction sites *Bgl* II/*Kpn* I, *Kpn* I/*Xba* I, or *Bgl* II/*Xba* I. Some triple alanine mutation constructs included a seven-aa extension (SRGPAVRR) after residue 1626. For FRET 2-hybrid constructs, fluorophore-tagged (all based on ECFP and EYFP) CaM constructs were made as described^[@R4]^. Other FRET constructs were made by replacing CaM with appropriate PCR amplified segments, via unique *Not* I and *Xba* I sites flanking CaM^[@R4]^. YFP-CaM~C~ ([Supplementary Fig. S4.1](#SD1){ref-type="supplementary-material"}) was YFP fused to the C-lobe of CaM (residues 78--149). To aid cloning, the YFP-tagged CI region was made with a 12 residue extension (SRGPYSIVSPKC) via *Not* I / *Xba* I sites as above. This linker did not alter apoCaM binding affinity versus wild-type YFP-tagged CI region (not shown). Throughout, all segments subject to PCR or QuikChange® mutagenesis were verified in their entirety by sequencing.

Transfection of HEK293 cells {#S11}
----------------------------

For whole-cell patch clamp experiments, HEK293 cells were cultured on 10-cm plates, and channels transiently transfected by a calcium phosphate method^[@R9]^. We applied 8 µg of cDNA encoding the desired channel α~1~ subunit, along with 8 µg of rat brain β~2a~ (M80545) and 8 µg of rat brain α~2~δ (NM012919.2) subunits. We utilized the β~2a~ auxiliary subunit to minimize voltage-dependent inactivation. For experiments involving CaM overexpression, we coexpressed 8 µg of rat CaM~WT~, CaM~12~, or CaM~34~, as described^[@R9]^. All of the above cDNA constructs were included within mammalian expression plasmids with a cytomegalovirus promoter. To boost expression, cDNA for simian virus 40 T antigen (1--2 µg) was co-transfected. For fluorescence resonance energy transfer (FRET) 2-hybrid experiments, HEK293 cells were cultured on glass-bottom dishes and transfected with FuGENE^R^ 6 (Roche), before epifluorescence microscope imaging^[@R4]^. Electrophysiology/FRET experiments were performed at room temperature 1--3 days after transfection.

Whole-cell recording {#S12}
--------------------

Whole-cell recordings were obtained using an Axopatch 200A amplifier (Axon Instruments). Electrodes were made from borosilicate glass capillaries (World Precision Instruments, MTW 150-F4), yielding 1--3 MΩ resistances which were in turn compensated for series resistance by \>70%. Currents were low-pass filtered at 2 kHz prior to digital acquisition at several times that frequency. A P/8 leak-subtraction protocol was used. The internal solution contained, (in mM): CsMeSO~3~, 114; CsCl~2~, 5; MgCl~2~, 1; MgATP, 4; HEPES (pH 7.4), 10; and BAPTA, 10; at 290 mOsm adjusted with glucose. The bath solution was (in mM): TEA-MeSO~3~, 102; HEPES (pH 7.4), 10; CaCl~2~ or BaCl~2~, 40; at 300 mOsm, adjusted with TEA-MeSO~3~.

FRET optical imaging {#S13}
--------------------

We conducted FRET 2-hybrid experiments in HEK293 cells cultured on glass-bottom dishes, using an inverted fluorescence microscope as extensively described by our laboratory^[@R4]^. Experiments utilized a bath Tyrode's solution containing either 2 mM Ca^2+^ for experiments probing apoCaM binding or 10 mM Ca^2+^ with 4 µM ionomycin (Sigma-Aldrich, MO) for elevated Ca^2+^ experiments. 3^3^-FRET efficiencies (*E*~A~) were computed as elaborated in our prior publications^[@R4]^. E-FRET efficiencies (*E*~D~), whose measurement methodology was developed and refined in other labortories^[@R41]^, could be determined from the same single-cell 3^3^-FRET measurements using the following relationship, which expresses *E*~D~ in terms of our own calibration metrics and standard measurements: $$E_{D} = E_{D,\textit{max}} \cdot D_{b} = \frac{S_{FRET} - R_{D1} \cdot S_{CFP} - R_{A} \cdot S_{YFP}}{S_{FRET} - R_{D1} \cdot S_{CFP} - R_{A} \cdot S_{YFP} + G \cdot S_{CFP}}$$ where *G* is a constant, defined as $$G = R_{D1}\frac{\varepsilon_{CFP}(440nm)}{\varepsilon_{YFP}(440{nm}{nm})}\frac{M_{A}}{M_{D}} \approx 1.864$$ *S*~FRET~, *S*~YFP~, and *S*~CFP~ correspond to fluorescent measurements from the same cell using FRET, YFP, and CFP cubes whose spectral properties have been detailed previously^[@R4]^. *R*~D1~ and *R*~A~ are constants relating to the respective spectral properties of ECFP and EYFP; ɛ~CFP~(440 nm) / ɛ~YFP~(440 nm) approximates the ratio of molar extinction coefficients of ECFP and EYFP at 440 nm, respectively; and *M*~A~/*M*~D~ is the ratio of optical gain factors and quantum yields pertaining to EYFP and ECFP, respectively. Detailed descriptions of these parameters and their determination appear in our prior publications^[@R4]^. For all FRET efficiencies, spurious FRET relating to unbound ECFP and EYFP moities has been subtracted^[@R13]^. For 3^3^-FRET, spurious FRET is linearly proportional to the concentration of CFP molecules, and the experimentally determined slopewas obtained from cells coexpressing ECFP and EYFP fluorophores. Similarly, for E-FRET, the spurious FRET is linearly proportional to the concentration of EYFP molecules. The slope for this relationship can be obtained from: $$A_{E - FRET} = A_{3^{3} - FRET} \cdot (R_{A}/R_{D1})/(M_{A}/M_{D})$$ The methods for FRET 2-hybrid binding curves have been extensively described in previous publications^[@R3],[@R4],[@R41]^. Briefly, binding curves were determined by least-squared-error minimization of data from multiple cells, utilizing a 1:1 binding model with adjustment of parameters *K*~d,EFF~ and maximal FRET efficiency at saturating donor concentrations. For a small number of interactions involving mutations that strongly disrupted binding, the maximal FRET efficiency was set equal to that of the corresponding wild-type interaction and *K*~d,EFF~ varied to minimize errors. Standard-deviation error bounds on *K*~d,EFF~ estimates were determined by Jacobian error matrix analysis^[@R58]^.

[Supplementary Note 24](#SD1){ref-type="supplementary-material"} characterizes our FRET 2-hybrid constructs, specifying their precise sequence composition, and behavior via western blot and confocal imaging analysis.

Molecular Modeling {#S14}
------------------

*De novo* structural prediction was performed using the *Robetta* online server^[@R49]^ (<http://robetta.bakerlab.org>) as described in [Supplementary Note 19,20--22](#SD1){ref-type="supplementary-material"}. We used web-based molecular docking programs, PatchDock^[@R52]^ (<http://bioinfo3d.cs.tau.ac.il/PatchDock/>) and FireDock^[@R59]^ (<http://bioinfo3d.cs.tau.ac.il/FireDock/>) to obtain preliminary models for molecular docking. Such preliminary models were subsequently used as starting models for further structural modeling and refinement using a customized docking protocol of PyRosetta^[@R60]^. A homology model of the C-lobe of apoCaM bound to IQ domain was constructed as described elsewhere^[@R42]^. All molecular models and atomic structures were visualized and rendered using PyMOL v1.2r1. (DeLano Scientific, LLC).
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![General schema for CaM regulation of representative L-type Ca~V~1.3 channels\
(**a**) Primary configurations of CaM/channel complex with respect to CaM-regulatory phenomena (*E*, *A*, *I*~C~, *I*~N~, and *I*~CN~). Inset at far right, cartoon of main channel landmarks involved in CaM regulation, with only the pore-forming α~1D~ subunit of Ca~V~1.3 diagrammed. Ca^2+^-inactivation (CI) region, in the proximal channel carboxy terminus (\~160 aa), contains elements potentially involved in CaM regulation. IQ domain (IQ), comprising the C-terminal \~30 aa of the CI segment, long proposed as preeminent for CaM/channel binding. Dual vestigial EF-hand (EF) motifs span the proximal \~100 aa of the CI module; these have been proposed to play a transduction role in channel regulation. [P]{.ul}roximal [C]{.ul}a^2+^-[i]{.ul}nactivating (PCI) region constitutes the CI element exclusive of the IQ domain. NSCaTE on channel amino terminus of Ca~V~1.2--1.3 channels may be the N-lobe Ca^2+^/CaM effector site. (**b**) Whole-cell Ca~V~1.3 currents expressed in HEK293 cell, demonstrating CDI in the presence of endogenous CaM only. CDI observed here can reflect properties of the entire system diagrammed in **a**, as schematized by the stick-figure diagram at the bottom of **b**. Here and throughout, the vertical scale bar pertains to 0.2 nA of Ca^2+^ current (black); and the Ba^2+^ current (gray) has been scaled \~3-fold downward to aid comparison of decay kinetics, here and throughout. Horizonal scale bar, 100 ms. (**c**) Currents during overexpression of CaM~WT~, isolating the behavior of the diamond-shaped subsystem at bottom. (**d**) Currents during overexpression of CaM~12~, isolating C-lobe form of CDI. (**e**) Currents during overexpression of CaM~34~, isolating N-lobe form of CDI. (**c--e**) Vertical bar, 0.2 nA Ca^2+^ current. Timebase as in **b**.](nihms454095f1){#F1}

![Probing functionally relevant CaM regulatory interactions via iTL analysis\
(**a**) Isolated C- or N-lobe regulatory system (denoted by stick-figure diagrams on left) can be coarsely represented by a five-state scheme on right. A single lobe of apoCaM begins preassociated to channel (state 1). Following disassociation (state 2), CaM may bind two Ca^2+^ ions (state 3, black dots). Ca^2+^/CaM may subsequently bind to channel effector site (state 4). From here, transduction step leads to state 5, equivalent to CDI. Association constant for lobe of apoCaM binding to preassociation site is ɛ; whereas γ~1~ and γ~2~ are association constants for respective transitions from states 3 to 4, and states 4 to 5. (**b**) Unique Langmuir relation ([Eq. 1](#FD1){ref-type="disp-formula"}) that will emerge upon plotting channel *CDI* (defined [Fig. 1b](#F1){ref-type="fig"}, right) as a function of *K*~a,EFF~ (association constant measured for isolated channel peptide), if *K*~a,EFF~ is proportional to one of the actual association constants in the scheme as in **a**. Black symbols, hypothetical results for various channel/peptide mutations; green symbol, hypothetical wild type. (**c**) Predicted outcome if peptide association constant *K*~a,EFF~ has no bearing on association constants within holochannels. (**d**) Outcome if mutations affect holochannel association constants, but not peptide association constants. (**e**) Outcome if mutations affect holochannel association constant(s) and peptide association constant, but in ways that are poorly correlated.](nihms454095f2){#F2}

![Inconsistencies with IQ domain role as Ca^2+^/CaM effector site\
(**a**) No appreciable deficit in isolated N-lobe CDI upon point alanine substitutions across the IQ domain (sequence at top with bolded isoleucine at '0' position). Left, corresponding subsystem schematic. Middle, bar-graph summary of *CDI* metric, as defined in [Fig. 1b](#F1){ref-type="fig"}. Bars, mean ± SEM for \~6 cells each. Green dashed line, wild-type profile; red bar, I\[0\]A; blue symbol in all panels, Y\[3\]D. Right, exemplar currents, demonstrating no change in N-lobe CDI upon I\[0\]A substitution. Horizontal scale bar, 100 ms; vertical scale bar, 0.2 nA Ca^2+^ current. Red, Ca^2+^ current; gray, Ba^2+^ current. (**b**) Isolated C-lobe CDI (corresponding subsystem schematized on left) exhibits significant attenuation by mutations surrounding the central isoleucine (colored bars). Format as in **a**. I\[0\]A shows the strongest attenuation (red bar and exemplar currents at right). Bars average \~5 cells ± SEM . Dashed green line, wild-type profile. Timebase as in **b**; vertical scale bar, 0.2 nA Ca^2+^ current . (**c**) Bar-graph summary of association constants (*K*~a,EFF~ = 1 / *K*~d,EFF~) for Ca^2+^/CaM binding to IQ, evaluated for constructs exhibiting significant effects in **b** (colored bars, with I\[0\]A in red), or chosen at random (hashed in **b**). Error bars, nonlinear standard-deviation estimates. FRET partners schematized on the left, and exemplar binding curves on the right for I\[0\]A (red) and wild-type (black). Symbols average \~7 cells. Smooth curve fits, 1:1 binding model. Calibration to efficiency *E*~A~ = 0.1, far right vertical scale bar. Horizontal scale bar corresponds to 100 nM. (**d**) Plots of N-lobe *CDI* versus *K*~a,EFF~ deviate from [Eq. 1](#FD1){ref-type="disp-formula"}, much as in [Fig. 2c](#F2){ref-type="fig"}. Green, wild type; red, I\[0\]A; blue, Y\[3\]D. (**e**) Plots of C-lobe *CDI* versus *K*~a,EFF~ also diverge from Langmuir, as in [Fig. 1e](#F1){ref-type="fig"}. This result further argues against the IQ *per se* acting as an effector site for the C-lobe of Ca^2+^/CaM. Symbols as in **d**. (**d, e**) Y\[3\]D (blue symbol, *CDI* mean of 4 cells) yields poor Ca^2+^/CaM binding, but unchanged CDI. [Supplementary Note 7](#SD1){ref-type="supplementary-material"}, further FRET data.](nihms454095f3){#F3}

![iTL analysis of Ca^2+^/CaM effector role of NSCaTE module of Ca~V~1.3 channels\
(**a**) Cartoon depicting NSCaTE as putative effector interface for N-lobe of Ca^2+^/CaM. (**b**) Exemplar Ca~V~1.3 whole-cell currents exhibiting robust isolated N-lobe CDI, as seen from the rapid decay of Ca^2+^ current (black trace). Corresponding stick-figure subsystem appears on the left. W\[44\]A mutation abolishes N-lobe CDI, as seen from the lack of appreciable Ca^2+^ current decay (red trace). Gray trace, averaged Ba^2+^ trace for wild-type (WT) and W\[44\]A constructs. Horizontal scale bar, 100 ms; vertical scale bar, 0.2 nA Ca^2+^ current (red, W44A; black, WT). (**c**) FRET 2-hybrid binding curves for Ca^2+^/CaM~34~ and NSCaTE segment, with FRET partners schematized on the left. Wild-type pairing (WT) in black; W\[44\]A mutant pairing in red. Each symbol, mean ± SEM of \~5 cells. (**d**) Bar-graph summary of N-lobe *CDI* for NSCaTE mutations measured after 800-ms depolarization, with NSCaTE sequence at the top, as numbered by position within Ca~V~1.3.. Data for W\[44\]A in red; dashed green line, wild type. Bars, mean ± SEM of \~5 cells. (**e**) Association constants (*K*~a,EFF~ = 1 / *K*~d,EFF~) for Ca^2+^/CaM~34~ binding to NSCaTE module evaluated for constructs exhibiting significant effects in panel **d**. Error bars, nonlinear standard deviation estimates. Data for W\[44\]A in red; dashed green line, wild type. (**f**) Plotting N-lobe *CDI* versus *K*~a,EFF~ uncovers a Langmuir, identifying NSCaTE as functionally relevant effector site. W\[44\]A in red; wild type in green. (**g-l**) iTL fails to uphold NSCaTE as effector site for C-lobe of Ca^2+^/CaM. Format as in **a--f**. (**h, j**) C-lobe CDI at 300 ms, unchanged by NSCaTE mutations. Bars in **j**, mean ± SEM of \~5 cells. (**i, k**) Changes in *K*~a,EFF~ of NSCaTE module for Ca^2+^/CaM~12~ via 3^3^-FRET. Each symbol in **i**, mean ± SEM of \~5 cells. (**l**) C-lobe *CDI* versus *K*~a,EFF~ deviates from Langmuir, as in [Fig. 2c](#F2){ref-type="fig"}.](nihms454095f4){#F4}

![iTL analysis of PCI segment as C-lobe Ca^2+^/CaM effector interface\
(**a**) Channel cartoon depicting PCI segment as putative effector site for C-lobe of Ca^2+^/CaM. (**b**) Isolated N-lobe CDI for wild type (WT) and LGF→AAA (LGF) mutant channels. Ca^2+^ current for WT in red, and for LGF in red. Gray, averaged Ba^2+^ trace. Horizontal scale bar, 100 ms; vertical scale bar, 0.2 nA Ca^2+^ current (red, LGF; black, WT). (**c**) Isolated C-lobe CDI for WT and LGF mutant channels, indicating strong CDI attenuation by LGF mutation. Format as in **b**. (**d**) FRET 2-hybrid binding curves for Ca^2+^/CaM pitted against PCI segments, for WT (black) and LGF (red). Each symbol, mean ± SEM from \~ 9 cells. (**e**) Bar-graph summary confirming no appreciable reduction of isolated N-lobe CDI, over all alanine scanning mutants across the PCI region (sequence at the top). Schematic of corresponding system under investigation at the left. Green dashed line, wild type; red, LGF mutant; gaps, nonexpressing configurations. Bars, mean ± SEM of \~5 cells. (**f**) Bar-graph summary, C-lobe *CDI* for alanine scan of PCI. Red bar, LGF→AAA mutant showing strong CDI reduction. Rose bar, other loci showing substantial CDI reduction. Hashed, randomly chosen loci for subsequent FRET analysis below. Bars, mean ± SEM of \~5 cells. (**e, f**) CDI decrease for YLT cluster (Fig. 5e, f) reflects reduced Ca^2+^ entry from 30-mV depolarizing shift in activation, not CDI attenuation *per se*. Shifts for all other loci were at most ±10 mV (not shown). (**g**) Association constants for Ca^2+^/CaM binding to PCI region, with FRET partners as diagrammed on the left. Green dashed line, wild-type profile. PCI mutations yielding large C-lobe *CDI* deficits were chosen for FRET analysis (red and rose in **f**), as well as those chosen at random (hashed in **f**). Error bars, nonlinear estimates of standard deviation. (**h**) Plots of N-lobe CDI versus *K*~a,EFF~ for Ca^2+^/CaM binding to PCI deviated from Langmuir. Red, LGF; green, WT. (**i**) Alternatively, plotting C-lobe CDI revealed Langmuir relation, supporting PCI as C-lobe Ca^2+^/CaM effector site. Symbols as in **h**.](nihms454095f5){#F5}

![Role of IQ domain in C-lobe CDI\
(**a**) Cartoon depicting putative binding interaction between IQ domain and PCI segment, which is also required for C-lobe CDI. (**b**) Bar-graph summary of C-lobe CDI measured for alanine scan of IQ domain, reproduced from [Fig. 3b](#F3){ref-type="fig"}. Strongest CDI reduction for I\[0\]A mutant (red), followed closely by loci affiliated with rose and blue bars underneath gray dashed-line. Dashed-green line, wild-type. (**c**) Association constants *K*~a,EFF~ determined for 3^3^-FRET binding between IQ domain and PCI region (partners diagrammed at left), under elevated levels of Ca^2+^. Wild-type profile, green dashed line. Bars, *K*~a,EFF~ for mutants with strongest effects (colored bars in **b**) or chosen at random (hashed bars in **b**). Error bars, nonlinear standard deviation estimates. (**d**) Exemplar 3^3^-FRET binding curves for IQ/PCI interaction. Each symbol, mean ± SEM of \~8 cells. Absent Ca^2+^, the IQ domain associates only weakly with the PCI region (gray). However, elevated Ca^2+^ greatly enhances binding (black). (**e**) 3^3^-FRET binding curves for I\[0\]A (red) and Q\[1\]A (blue) mutations under elevated Ca^2+^. Each symbol, mean ± SEM of \~5 cells. Fit for wild type IQ/PCI interaction reproduced from **d** in black. (**f**) Plotting C-lobe CDI versus *K*~a,EFF~ under elevated Ca^2+^ unveils a well-resolved Langmuir relation. WT (green), I\[0\]A (red), and Q\[1\]A (blue).](nihms454095f6){#F6}

![Footprint of apoCaM preassociation with the PCI segment\
(**a**) Channel cartoon depicting apoCaM preassociated with the CI region, with C-lobe engaging IQ domain, and N-lobe associated with PCI region. (**b**) Whole-cell currents for TVM→AAA mutant in the PCI segment (Ca^2+^ in red; Ba^2+^ in gray), with only endogenous CaM present. Horizontal scale bar, 100 ms; vertical scale bar, 0.2 nA Ca^2+^ current. (**c**) Overexpressing CaM~WT~ rescues CDI for TVM→AAA mutation, suggesting that PCI region harbors an apoCaM preassociation locus. Format as in **b**. (**d**) 3^3^-FRET binding curves show strong apoCaM binding to CI region. Wild type (WT) in black; TVM→AAA in red. Each symbol, mean ± SEM of \~7 cells. (**e**) Bar-graph summary of CDI with only endogenous CaM present (*CDI*~CaMendo~), across alanine scan of PCI region. TVM→AAA (red) shows strongest effect, with rose colored bars also showing appreciable CDI reduction. Bars, mean ± SEM of \~5 cells. Left, schematic of relevant CaM subsystem. (**f**) Bar-graph summary of CDI rescue upon overexpressing CaM~WT~ (*CDI*~CaMhi~), for mutations showing significant loss of CDI (colored bars in **e**), or chosen at random (hashed bars in **e**). Bars, mean ± SEM of \~5 cells. Corresponding subsystem of regulation on the left. (**g**) Bar-graph summary of *K*~a,EFF~ for apoCaM binding to CI region, with partners as sketched on the left. Data obtained for nearly all mutants with significant CDI reduction (colored in **e**), and for some mutants chosen at random (hashed in **e**). Error bars, nonlinear estimates of standard deviation. (**h**) iTL analysis confirms role of PCI as functionally relevant apoCaM site. Plotting *CDI*~CaMendo~/*CDI*~CaMhi~ (**e** and **f**) versus *K*~a,EFF~ for apoCaM/CI binding uncovers well-resolved Langmuir relation. TVM→AAA, red; WT, green. (**i**) Overlaying like data for IQ-domain analysis presented elsewhere^[@R42]^ (blue symbols here) displays remarkable agreement, consistent with the same apoCaM binding both PCI and IQ domains. Deep blue symbols, A\[−4\], I\[0\], F\[+4\] hotspots for apoCaM interaction with IQ element.](nihms454095f7){#F7}

![New view of CaM regulatory configurations of Ca~V~1.3 channels\
(**a**) Molecular layout of configurations *A*, *I*~C~, *I*~N~, and *I*~CN~ for conceptual scheme in [Fig. 1a](#F1){ref-type="fig"}. ApoCaM preassociates with CI region: C-lobe articulates IQ domain, and N-lobe engages the PCI segment. Once Ca^2+^ binds CaM, the N-lobe of Ca^2+^/CaM departs to NSCaTE on channel amino terminus, eliciting N-lobe CDI (*I*~N~). Alternatively, the C-lobe of Ca^2+^/CaM migrates to PCI segment, recruiting IQ domain to tri-partite complex (*I*~C~). Finally, *I*~CN~ corresponds to channel that has undergone both N- and C-lobe CDI. (**b**) *De novo* model of Ca~V~1.3 CI region docked to apoCaM (PCI region: green; IQ domain: blue). ApoCaM hotspots ([Fig. 6e--g](#F6){ref-type="fig"}) in red. C-lobe of apoCaM contacts IQ, while N-lobe binds EF-hand region. (**c**) Left, atomic structure of NSCaTE bound to N-lobe of Ca^2+^/CaM (2LQC^[@R33]^). NSCaTE peptide in tan; and N-lobe Ca^2+^/CaM in cyan. Ca^2+^, yellow. N-lobe CDI hotspots on NSCaTE in red. Right, *de novo* model of tripartite IQ-PCI-Ca^2+^/CaM complex (PCI region, green; IQ domain, blue). C-lobe CDI hotspots in red for both PCI and IQ domains.](nihms454095f8){#F8}
